What is the 13F Pro Quality Score for HCA?

13F Pro ranks HCA Healthcare, Inc. (HCA) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View HCA's current score at https://13fpro.ai/research/HCA (free sign-up required for the full ranking).

Which hedge funds own the most HCA stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of HCA include BlackRock,, VANGUARD CAPITAL MANAGEMENT, Sanders Capital,. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/research/HCA as soon as new 13F filings post.

Where does 13F Pro source HCA data?

All HCA Healthcare, Inc. fundamentals and ownership data come directly from SEC EDGAR. HCA Healthcare, Inc. files with the SEC under CIK 860730. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is HCA in?

HCA Healthcare, Inc. (HCA) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

What drives HCA's revenue?

Per HCA Healthcare, Inc.'s latest 10-Q filed with the SEC on 2026-04-29, the biggest revenue drivers are: Managed care and insurers ($9.1B, +0.5% YoY); Managed Medicare ($3.5B, +6.3% YoY); Medicare ($3.1B, +5.6% YoY). Figures are extracted from the filing text and machine-verified against the document. Full breakdown at https://13fpro.ai/research/HCA.

What are HCA's largest expenses?

HCA Healthcare, Inc.'s latest 10-Q reports these as the largest expense items: Salaries and benefits ($8.3B, +3.6% YoY); Supplies ($2.9B, +3.2% YoY); Other operating expenses ($4.2B, +8.7% YoY). Sourced directly from SEC EDGAR filing text for Q1 2026 (quarter ended March 31, 2026).

How often is HCA research updated on 13F Pro?

HCA's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

HCA Healthcare, Inc.(HCA)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →NYSE

Institutional-grade research for retail investors

SEC EDGAR: CIK 860730 HCA stock profile & AI dashboard →

13F Pro Quality Score

70.5/100

Rank #305 of 2,879 stocksTOP 25%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

58.7/100

Profitability

66.2/100

Balance Sheet

88.0/100

Earnings Quality

57.4/100

Free Cash Flow

63.9/100

Institutional Flow

30.0/100

Revenue Scale

98.2/100

Dilution Risk

73.9/100

HCA Stock Analysis & AI Quality Score

AI stock analysis and institutional research for HCA Healthcare, Inc. (HCA), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores HCA at 70.5/100 on a 32-signal composite quality model, placing it at rank #305 of 2,879 stocks — the top 25% of the AI-ranked universe. HCA scores in the top quartile across revenue scale (98.2), balance sheet strength (88.0). Areas of concern include institutional flow (30.0), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), HCA Healthcare, Inc. reports quarterly revenue of $19.1B, net income of $1.6B, an operating margin of 12.0%. Top institutional holders of HCA by reported 13-F value include BlackRock,, VANGUARD CAPITAL MANAGEMENT, Sanders Capital,, based on the most recent SEC filings. HCA trades on the NYSE exchange and files with the SEC under CIK 860730. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HCA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for HCA Healthcare, Inc. directly from SEC EDGAR. HCA Healthcare, Inc.'s 13F Pro composite quality score has ranged between 8 and 72 since 2021, currently 70.5 — a stable long-term trajectory across 56 quarterly and live scoring snapshots.

What's Driving HCA's Business? Latest 10-Q Breakdown

AI-extracted from HCA Healthcare, Inc.'s 10-Q filed 2026-04-29 — Q1 2026 (quarter ended March 31, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

HCA Healthcare reported Q1 2026 revenue of $19.1B (+4.3% YoY), with net income of $1.62B ($7.15 diluted EPS), as uninsured admissions surged 15.5% following expiration of enhanced premium tax credits.

Biggest Revenue Drivers

Total revenue: $19.1B+4.3% YoY

Managed care and insurers$9.1B+0.5% YoY

Unfavorably impacted by expiration of enhanced premium tax credits at end of 2025 and administrative reforms for marketplace insurance

Managed Medicare$3.5B+6.3% YoY

Grew from $3.3B in Q1 2025

Medicare$3.1B+5.6% YoY

Grew from $2.9B in Q1 2025

Largest Expense Items

Salaries and benefits$8.3B+3.6% YoY

Increased 43.3% of revenues vs. 43.6% prior year; per equivalent admission increased 2.4%

Supplies$2.9B+3.2% YoY

Medical devices +4.8%, pharmacy supplies -4.6%, general supplies +0.7% per equivalent admission

Other operating expenses$4.2B+8.7% YoY

Growth in state supplemental Medicaid program expenses, higher professional fees, increased technology investments, inflation impact

Interest expense$584M+6.8% YoY

Average debt balance $47.2B vs. $43.7B prior year; average effective rate 5.0% vs. 5.1%

Margins: Operating income margin declined to 12.0% from 12.7% YoY, driven by higher operating expenses as percentage of revenue, particularly state Medicaid programs and technology investments, partially offset by improved salaries-and-benefits ratio.

Watch Items from the Filing

Uninsured admissions increased 15.5% same-facility YoY, reflecting expiration of enhanced premium tax credits; uninsured admissions now represent 7% of total admissions vs. 6% prior year.
102 hospitals in Texas and Florida generated 59% of admissions and 51% of revenues in Q1 2026; 73% of uninsured admissions concentrated in these two states.
Total debt increased to $48.0B at March 31, 2026 from $46.5B at December 31, 2025; working capital deteriorated to negative $3.2B due to $3.6B increase in short-term borrowings and debt due within one year.
Estimated cost of total uncompensated care increased to $1.25B in Q1 2026 from $1.06B in Q1 2025 (+18.7%), driven by increased uninsured patient volume.
Several states with pending CMS applications for Medicaid directed payment programs could result in significant additional revenues if approved, timing and amount uncertain.

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Read the full 10-Q on SEC EDGAR →Share on X

Revenue

Q1 2026

$19.1B

Net Income

Q1 2026

$1.6B

Free Cash Flow

Q1 2026

$895.0M

Operating Margin

Q1 2026

12.0%

ROIC

Q1 2026

6.0%

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+7.1% YoY

$75.60BFY 2025

FY22 $60.23BFY23 $64.97BFY24 $70.60BFY25 $75.60B

Net Income

+17.8% YoY

$6.78BFY 2025

FY22 $5.64BFY23 $5.24BFY24 $5.76BFY25 $6.78B

EPS (Diluted)

+28.8% YoY

$28.33FY 2025

FY22 $19.15FY23 $18.97FY24 $22.00FY25 $28.33

Total Assets

+2.0% YoY

$60.72BFY 2025

FY22 $52.44BFY23 $56.21BFY24 $59.51BFY25 $60.72B

Total Debt

+8.0% YoY

$46.49BFY 2025

FY22 $38.45BFY23 $42.02BFY24 $43.03BFY25 $46.49B

Op. Cash Flow

+20.2% YoY

$12.64BFY 2025

FY22 $8.52BFY23 $9.43BFY24 $10.51BFY25 $12.64B

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2019	FY 2018
Revenue	$75.60B +7.1%	$70.60B +8.7%	$64.97B +7.9%	$60.23B +17.3%	$51.34B +10.0%	$46.68B
Net Income	$6.78B +17.8%	$5.76B +9.9%	$5.24B -7.1%	$5.64B +61.0%	$3.50B -7.4%	$3.79B
EPS (Diluted)	$28.33 +28.8%	$22.00 +16.0%	$18.97 -0.9%	$19.15 +90.2%	$10.07 -5.5%	$10.66
Total Assets	$60.72B +2.0%	$59.51B +5.9%	$56.21B +7.2%	$52.44B +16.4%	$45.06B +14.9%	$39.21B
Total Debt	$46.49B +8.0%	$43.03B +2.4%	$42.02B +9.3%	$38.45B +13.5%	$33.87B +0.8%	$33.61B
Operating Cash Flow	$12.64B +20.2%	$10.51B +11.5%	$9.43B +10.7%	$8.52B +12.1%	$7.60B +12.4%	$6.76B

AI Insight: HCA Financial Trends

HCA delivered 9.3% revenue growth from Q2 2024 to Q1 2026 but negative equity deepened dramatically to -$6.3B.

• Revenue grew steadily from $17.5B in Q2 2024 to $19.1B in Q1 2026, up 9.3%.

• Net income remained relatively stable, ranging between $1.3B-$1.9B across all quarters.

• Operating cash flow volatile, swinging from $1.7B in Q1 2025 to $4.4B in Q3 2025.

⚠ Negative equity deteriorated significantly from -$1.6B in Q2 2024 to -$6.3B in Q1 2026.

⚠ Total debt increased from $45.5B to $48.0B over the period despite strong cash generation.

AI Insight: HCA Ratio Trends

HCA's operating margin peaked at 13.7% in Q4 2025 but retreated to 12.0% in Q1 2026, while ROIC remains elevated above 20%.

• Operating margin improved from 10.9% in Q3 2024 to 13.7% in Q4 2025 before declining to 12.0% in Q1 2026.

• ROIC expanded from 16.8% in Q3 2024 to 26.4% in Q4 2025, though moderated to 21.9% in Q1 2026.

• Net profit margin peaked at 9.6% in Q4 2025, the highest level across the observed period.

⚠ Operating margin dropped 170bp from Q4 2025 peak to Q1 2026, first meaningful decline since Q3 2024.

⚠ ROIC declined from 26.4% in Q4 2025 to 21.9% in Q1 2026, breaking four consecutive quarters of improvement.

Get alerted when HCA's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for HCA Healthcare, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of HCA

BlackRock, Inc.
$6.3B13,363,266 sh
VANGUARD CAPITAL MANAGEMENT LLC
$4.8B10,178,362 sh
Sanders Capital, LLC
$4.2B8,957,145 sh
STATE STREET CORP
$3.6B7,539,550 sh
FMR LLC
$2.1B4,401,023 sh
WELLINGTON MANAGEMENT GROUP LLP
$1.8B3,907,712 sh
GEODE CAPITAL MANAGEMENT, LLC
$1.7B3,692,513 sh
First Eagle Investment Management, LLC
$1.5B3,254,570 sh
Capital International Investors
$1.4B3,033,612 sh
VANGUARD PORTFOLIO MANAGEMENT LLC
$1.3B2,757,779 sh

Fund	Value	Shares
BlackRock, Inc.	$6.3B	13,363,266
VANGUARD CAPITAL MANAGEMENT LLC	$4.8B	10,178,362
Sanders Capital, LLC	$4.2B	8,957,145
STATE STREET CORP	$3.6B	7,539,550
FMR LLC	$2.1B	4,401,023
WELLINGTON MANAGEMENT GROUP LLP	$1.8B	3,907,712
GEODE CAPITAL MANAGEMENT, LLC	$1.7B	3,692,513
First Eagle Investment Management, LLC	$1.5B	3,254,570
Capital International Investors	$1.4B	3,033,612
VANGUARD PORTFOLIO MANAGEMENT LLC	$1.3B	2,757,779

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put HCA on your watchlist

Track score changes the day HCA Healthcare, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is HCA a good stock to buy?

13F Pro's AI-powered analysis of HCA Healthcare, Inc. (HCA) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for HCA are available on the HCA stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own HCA?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling HCA. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of HCA Healthcare, Inc.'s investment landscape.